Benign Prostatic Hyperplasia and Male Lower Urinary Tract Symptoms: Epidemiology and Risk Factors.
about
Invasive urodynamic studies for the management of lower urinary tract symptoms (LUTS) in men with voiding dysfunctionInvasive urodynamic studies for the management of LUTS in men with voiding dysfunctionRecent advances in treatment for Benign Prostatic HyperplasiaPhosphodiesterase type 5 inhibitors for treating erectile dysfunction and lower urinary tract symptoms secondary to benign prostatic hyperplasia: A comprehensive reviewThe prevalence of benign prostatic hyperplasia in mainland China: evidence from epidemiological surveysEffect of pulsed electromagnetic field therapy on prostate volume and vascularity in the treatment of benign prostatic hyperplasia: a pilot study in a canine model.Testosterone and 17β-estradiol induce glandular prostatic growth, bladder outlet obstruction, and voiding dysfunction in male miceCan we use baseline characteristics to assess which men with moderately symptomatic benign prostatic hyperplasia at risk of progression will benefit from treatment? A post hoc analysis of data from the 2-year CONDUCT study.Obesity-induced diabetes and lower urinary tract fibrosis promote urinary voiding dysfunction in a mouse modelLower urinary tract symptoms: thinking beyond the urinary tract.The influence of depression, anxiety and somatization on the clinical symptoms and treatment response in patients with symptoms of lower urinary tract symptoms suggestive of benign prostatic hyperplasia.Benign prostatic hyperplasia is a significant risk factor for bladder cancer in diabetic patients: a population-based cohort study using the National Health Insurance in Taiwan.Medical attendance for lower urinary tract symptoms is associated with subsequent increased risk of outpatient visits and hospitalizations based on a nationwide population-based database.A cost-minimisation analysis comparing photoselective vaporisation (PVP) and transurethral resection of the prostate (TURP) for the management of symptomatic benign prostatic hyperplasia (BPH) in Queensland, Australia.Community-based research on the benign prostatic hyperplasia prevalence rate in Korean rural area.The Relationship between Depression, Anxiety, Somatization, Personality and Symptoms of Lower Urinary Tract Symptoms Suggestive of Benign Prostatic HyperplasiaGenetic Determinants of Metabolism and Benign Prostate Enlargement: Associations with Prostate Volume.Comparison of thulium laser enucleation and plasmakinetic resection of the prostate in a randomized prospective trial with 5-year follow-up.Depression and Its Severity Are Strongly Associated with Both Storage and Voiding Lower Urinary Tract Symptoms Independently of Prostate Volume.The Differential Expression and Function of the Inflammatory Chemokine Receptor CXCR5 in Benign Prostatic Hyperplasia and Prostate CancerMen With Severe Lower Urinary Tract Symptoms Are at Increased Risk of DepressionNF-κB and androgen receptor variant expression correlate with human BPH progressionNF-κB and androgen receptor variant 7 induce expression of SRD5A isoforms and confer 5ARI resistance.Sex steroid receptor expression and localization in benign prostatic hyperplasia varies with tissue compartmentErectile dysfunction and lower urinary tract symptoms: a consensus on the importance of co-diagnosis.Urinary Tract Symptoms (LUTS) Secondary to Benign Prostatic Hyperplasia (BPH) and LUTS/BPH with Erectile Dysfunction in Asian Men: A Systematic Review Focusing on Tadalafil.Comparison of outpatient versus inpatient transurethral prostate resection for benign prostatic hyperplasia: Comparative, prospective bi-centre study.Are lower urinary tract symptoms in men associated with cardiovascular diseases in a primary care population: a registry study.Prospective study of Type 2 diabetes mellitus, anti-diabetic drugs and risk of prostate cancer.Benign prostatic hyperplasia: a new metabolic disease of the aging male and its correlation with sexual dysfunctions.Factors related to receipt of non-cancer-related transurethral prostatectomy: findings from a large prospective study of 106 769 middle-aged and older Australian menTestosterone deficiency, cardiac health, and older men.Robotic-assisted simple prostatectomy: a systematic review and report of a single institution case series.Non-Hormonal treatment of BPH/BOONonsteroidal anti-inflammatory drugs and prostatic diseasesAvanafil for the treatment of erectile dysfunction: a multicenter, randomized, double-blind study in men with diabetes mellitusIs multichannel urodynamic assessment necessary before considering a surgical treatment of BPH? Pros and cons.Dietary Antioxidants and Longitudinal Changes in Lower Urinary Tract Symptoms in Elderly Men: The Osteoporotic Fractures in Men Study.Lower urinary tract symptoms, benign prostatic hyperplasia and metabolic syndrome.Bacteriological Profile of Isolates From Urine Samples in Patients of Benign Prostatic Hyperplasia and or Prostatitis Showing Lower Urinary Tract Symptoms.
P2860
Q24186369-B6B30707-D9E4-44B7-947B-53A07FAA40FAQ24194219-3B6A58CE-2459-4DEA-8829-03AFAB276D1EQ26766218-35FC25A6-E8E2-48A4-BEFC-63CF481E42CBQ26785752-1EE99472-5AA9-4ADE-8617-60F6262A7005Q28082321-671B7680-40F2-4E21-AB04-A86E77C44101Q30432283-D5BAB491-1600-4529-848A-66C6F542B1A8Q30525673-7CE16A97-1775-4B1C-892D-4CAC5BD3CAD2Q31110115-800403E9-6F55-4482-831B-FF4E958B489DQ33908275-D0AC5AC5-F989-47E5-B9F2-52B3E07099F7Q33956004-ACEE7740-AC9F-4436-B7F8-D14BF50D08EAQ34030026-48F0F33E-F5CD-4595-8C4B-FA50B688D4C8Q34535741-A3677551-2026-41ED-BEA1-7B023982F6BEQ34614481-17D34FA8-C4F4-4478-8AA5-E3EEDB708ED7Q34662522-86EC25B9-9F5F-4EF2-B689-63E4550612CFQ34962509-60C717E5-001A-45A5-B8A8-63AD1CB52920Q35330693-E0064841-274D-4E5D-9DAD-B7AD98DBFF24Q35687087-62A20E43-1649-427B-8C92-60F9FF59BE8AQ36146243-4CD7849F-D3B1-49AA-979D-9EEC25C3D8D3Q36241740-1916258B-EDD7-4366-8632-74F152C663ACQ36274988-C964C728-F7F4-4C51-B3C2-DB86009F4284Q36438266-068E7306-1338-41F8-B98E-A239D1D55D68Q36606285-3937FE38-687F-4CC8-B6B8-C7FA560DB286Q37018606-DDCB9661-9BCF-46E1-807B-A182D039B76BQ37060725-6000E494-986D-427F-AB7B-C25AD0A31135Q37108885-99269074-524C-436A-8B56-CD30A87D45DFQ37466573-F712FED9-97F5-4C42-9FFF-1579C98221B9Q37496451-1564E105-C832-4754-9D62-C1F57D048994Q37502247-94A11D08-758A-45F9-8929-B601A2E3B129Q37561605-7FDE6760-B1E4-4405-920E-98033FD3A724Q37618958-BB744CEE-1A40-48E7-B33A-3125C7B3973EQ37639947-C71E1195-0BF6-4CE9-AFAC-B1D31DFE7764Q37724941-94061D70-E7F2-4FF4-9684-C98B17FC27E0Q38169997-DF53BE65-9E3C-416F-947C-B91A3DF08769Q38205423-19CA2140-3E88-4900-86F0-38BF4EC11186Q38217858-90EA2980-271A-43DF-8EE0-2A4E231DE22DQ38466768-F09F2354-38CD-4C0B-86B3-E89A63B5E960Q38555382-67F7B4B4-065F-4FB4-9493-F342FCBF0E01Q38672180-5434CFB8-3C31-4D12-843F-AE5753C0D827Q38692706-43CD8D39-95CA-442B-A358-F5628066E58CQ39149948-7AF85E08-2398-480A-A0BE-77B5530AF053
P2860
Benign Prostatic Hyperplasia and Male Lower Urinary Tract Symptoms: Epidemiology and Risk Factors.
description
2010 nî lūn-bûn
@nan
2010 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
Benign Prostatic Hyperplasia a ...... Epidemiology and Risk Factors.
@ast
Benign Prostatic Hyperplasia a ...... Epidemiology and Risk Factors.
@en
Benign Prostatic Hyperplasia a ...... Epidemiology and Risk Factors.
@nl
type
label
Benign Prostatic Hyperplasia a ...... Epidemiology and Risk Factors.
@ast
Benign Prostatic Hyperplasia a ...... Epidemiology and Risk Factors.
@en
Benign Prostatic Hyperplasia a ...... Epidemiology and Risk Factors.
@nl
prefLabel
Benign Prostatic Hyperplasia a ...... Epidemiology and Risk Factors.
@ast
Benign Prostatic Hyperplasia a ...... Epidemiology and Risk Factors.
@en
Benign Prostatic Hyperplasia a ...... Epidemiology and Risk Factors.
@nl
P2860
P1476
Benign Prostatic Hyperplasia a ...... Epidemiology and Risk Factors.
@en
P2093
J Kellogg Parsons
P2860
P2888
P304
P356
10.1007/S11884-010-0067-2
P577
2010-09-07T00:00:00Z
P5875
P6179
1034918489